Valiant Laboratories Ltd Quarterly Results
Q3 FY25-26 Results Summary
Revenue
The revenue stands at ₹52.46 crore, reflecting a quarter-on-quarter *(QoQ) increase of 13.55 per cent from ₹46.20 crore. This corresponds to a year-on-year *(YoY) growth of 48.91 per cent.
Operating Profit
Operating Profit stands at ₹-0.89 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 1,212.50 per cent from ₹0.08 crore. This corresponds to a year-on-year *(YoY) decline of 243.55 per cent.
PBDT
PBDT stands at ₹-0.94 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 217.50 per cent from ₹0.80 crore. This corresponds to a year-on-year *(YoY) decline of 143.72 per cent.
Profit Before Tax
Profit Before Tax stands at ₹-2.99 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 1,207.41 per cent from ₹0.27 crore. This corresponds to a year-on-year *(YoY) decline of 283.44 per cent.
Net Profit
Net Profit stands at ₹-7.06 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 3,630.00 per cent from ₹0.20 crore. This represents a 400.43 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Valiant Laboratories Ltd Earnings
- YOY
- QOQ
Valiant Laboratories Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Valiant Laboratories Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Valiant Laboratories Ltd Financial Reports
Valiant Laboratories Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Valiant Laborato | -1.40% | -3.67% | 21.35% | 26.85% | -3.66% | -20.39% |
| Haleos Labs Limited | 1.44% | 5.45% | 31.74% | 31.85% | 30.89% | 18.67% |
| Jenburkt Pharma | 0.36% | -1.09% | 14.47% | 9.64% | -5.88% | 12.86% |
| Albert David | -4.18% | -2.90% | 5.64% | 4.31% | -5.41% | -7.36% |
| Medicamen Biotec | -6.50% | -6.47% | 11.04% | -18.97% | -33.38% | -38.05% |
| Astal Lab | -5.71% | 10.50% | 22.26% | 6.42% | -12.83% | -2.21% |
| Medico Remedies | 2.87% | -0.86% | 7.66% | -14.19% | -22.26% | -23.69% |
Company Info
Company Information
Chairman & Independent Directo : Mulesh Manilal Savla
ED / MD / Promoter : Santosh S. Vora
ED / WTD / CFO / Promoter : Paresh Shashikant Shah
Non Executive Director : Shantilal Shivji Vora
Non Executive Director : Sandeep Gupta
Independent Non Exe. Director : Sona! A. Vira
Independent Non Exe. Director : Ashok Lakhamshi Chheda
Company Sec. & Compli. Officer : Akshay Gangurde